Skip to main content

Peer Review reports

From: Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial

Original Submission
31 Jul 2020 Submitted Original manuscript
17 Aug 2020 Author responded Author comments - Jay C. Horrow
Resubmission - Version 2
17 Aug 2020 Submitted Manuscript version 2
17 Nov 2020 Author responded Author comments - Jay C. Horrow
Resubmission - Version 3
17 Nov 2020 Submitted Manuscript version 3
21 Dec 2020 Author responded Author comments - Jay C. Horrow
Resubmission - Version 4
21 Dec 2020 Submitted Manuscript version 4
6 Jan 2021 Reviewed Reviewer Report
12 Jan 2021 Reviewed Reviewer Report - Issam Tanoubi
4 Feb 2021 Author responded Author comments - Jay C. Horrow
Resubmission - Version 5
4 Feb 2021 Submitted Manuscript version 5
10 Feb 2021 Author responded Author comments - Jay C. Horrow
Resubmission - Version 6
10 Feb 2021 Submitted Manuscript version 6
Publishing
11 Feb 2021 Editorially accepted
27 Feb 2021 Article published 10.1186/s12871-021-01278-w

You can find further information about peer review here.

Back to article page